You have 9 free searches left this month | for more free features.

FAP

Showing 1 - 25 of 288

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

Recruiting
  • Non Small Cell Lung Cancer
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Oct 24, 2023

Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission

Recruiting
  • Solid Tumors, Adult
  • Metastatic Cancer
  • Gallium-68 labelled (68Ga-) FAP-2286
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 1, 2022

SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)

Recruiting
  • SSTR2
  • +2 more
  • 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
May 24, 2023

Cancer Trial in Wuxi (18F-FAPI, 68Ga-FAPI)

Recruiting
  • Cancer
  • Wuxi, China
    Affiliated Hospital of Jiangnan University
Jan 19, 2023

Tumor Trial in Fuzhou (68Ga-FAP-RGD)

Recruiting
  • Tumor
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 23, 2022

Tumor, Positron-Emission Tomography Trial in Fuzhou (68Ga-FAP-CHX)

Recruiting
  • Tumor
  • Positron-Emission Tomography
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 17, 2022

Visualization of Papilla Through Use of NuView Device in FAP

Not yet recruiting
  • Familial Adenomatous Polyposis
    • (no location specified)
    Jan 5, 2023

    Solid Tumor Trial in United States (68Ga-FAP-2286, 177Lu-FAP-2286)

    Recruiting
    • Solid Tumor
    • Birmingham, Alabama
    • +5 more
    Aug 26, 2022

    Familial Adenomatous Polyposis Trial in Marrero, Salt Lake City (REC-4881, Placebo)

    Recruiting
    • Familial Adenomatous Polyposis
    • Marrero, Louisiana
    • +1 more
    Jan 21, 2023

    Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG)

    Recruiting
    • Tumor, Solid
    • Positron-Emission Tomography
    • 18F-FDG
    • Xiamen, Fujian, China
      The First affiliated hospital of xiamen university
    Aug 8, 2022

    Liver Fibrosis, Pulmonary Fibrosis, Myocardial Fibrosis Trial in San Francisco (68Ga-FAP-2286, Positron Emission Tomography

    Recruiting
    • Liver Fibrosis
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 5, 2022

    Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)

    Recruiting
    • Tumor, Solid
    • Positron-Emission Tomography
    • 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
    • Xiamen, Fujian, China
      The First Affiliated Hospital of Xiamen University
    Sep 16, 2022

    Tumor, Solid Trial in Essen (68Ga-FAPI-46 PET Scan)

    Recruiting
    • Tumor, Solid
    • 68Ga-FAPI-46 PET Scan
    • Essen, NRW, Germany
      Department of Nuclear medicine, University hospital Essen
    Dec 15, 2021

    Familial Adenomatous Polyposis Trial in Bologna (Eicosapentaenoic acid free fatty acid (EPA-FFA), Placebo)

    Recruiting
    • Familial Adenomatous Polyposis
    • Eicosapentaenoic acid free fatty acid (EPA-FFA)
    • Placebo
    • Bologna, Italy
      University of Bologna and St.Orsola-Malpighi Hospital
    Oct 26, 2022

    Familial Adenomatous Polyposis Trial in Amsterdam (Lithium Carbonate)

    Enrolling by invitation
    • Familial Adenomatous Polyposis
    • Lithium Carbonate
    • Amsterdam, Noord-Holland, Netherlands
      Academic Medical Centre
    Jun 22, 2022

    PET/CT, FAPI, Oral Cancer Trial in Wuhan (68Ga-DOTA-FAPI, PET/CT)

    Recruiting
    • PET/CT
    • +2 more
    • Wuhan, Hubei, China
      Zhongnan Hopital of Wuhan University
    Dec 30, 2021

    Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40

    Recruiting
    • Advanced Malignant Solid Tumor
    • MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPinĀ® drug candidate
    • Lyon, Cedex 08, France
    • +3 more
    Nov 4, 2022

    Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma Trial in Puerto Rico, United States

    Not yet recruiting
    • Familial Adenomatous Polyposis
    • Obeticholic Acid
    • Placebo
    • Phoenix, Arizona
    • +4 more
    Nov 18, 2021

    PDAC - Pancreatic Ductal Adenocarcinoma, FAP Trial in New York ([68Ga]FAPI-46)

    Recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • FAP
    • New York, New York
      NYU Langone Health
    May 3, 2022

    Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma Trial in Puerto Rico, United States

    Recruiting
    • Attenuated Familial Adenomatous Polyposis
    • +3 more
    • Biopsy
    • +2 more
    • Scottsdale, Arizona
    • +5 more
    Dec 30, 2022

    The Pancreas Interception Center for Early Detection,

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +12 more
    • Data collection
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 11, 2023

    Solid Tumor, Unspecified, Adult Trial in Singapore (177Lu-LNC1004 Injection group 1 radionuclide therapy, 177Lu-LNC1004

    Not yet recruiting
    • Solid Tumor, Unspecified, Adult
    • 177Lu-LNC1004 Injection group 1 radionuclide therapy
    • +3 more
    • Singapore, Singapore
      National University Cancer Institute, Singapore National Univers
    Feb 1, 2023

    Abdominal Pain Trial in Milano, Milan (L. reuteri protectis, Placebo tablet)

    Terminated
    • Abdominal Pain
    • L. reuteri protectis
    • Placebo tablet
    • Milano, Italy
    • +1 more
    May 28, 2021

    Schizophrenia Trial in Moscow, Stavropol' (VLT-015)

    Recruiting
    • Schizophrenia
    • Moscow, Moscow Region, Russian Federation
    • +1 more
    Aug 22, 2022

    Liver Fibrosis, FAP, Positron Emission Tomography Trial in Qingdao (18F-FAPI)

    Recruiting
    • Liver Fibrosis
    • +2 more
    • 18F-FAPI
    • Qingdao, Shandong, China
      The Affiliated Hospital of Qingdao University
    Feb 21, 2022